Home > News > Nanorods Deliver Vaccines, Trigger Strong Immune Response
June 1st, 2005
Nanorods Deliver Vaccines, Trigger Strong Immune Response
Abstract:
Gene-based vaccines, which use DNA to induce immune system cells to mount a targeted immune response, hold promise for treating and preventing cancer, but delivering DNA to the proper cells has proven difficult. Now, a multi-institutional team of collaborators has shown that DNA-bearing nanorods delivered to immune cells through the skin will trigger a strong antibody response. Nanorods may prove to be particularly useful in vaccination applications because they can be modified to carry multiple antigens as well as chemicals that stimulate the immune system to respond to antigens.
Source:
NCI
Bookmark:
| Related Links |
Johns Hopkins School of Medicine
| Related News Press |
Possible Futures
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||